---
title: "NAPP LABORATORIES LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0f811bf9-0b65-5d10-a9ae-0bc5fa38eeaa
json: https://whiteintel.dev/api/public/dossier/0f811bf9-0b65-5d10-a9ae-0bc5fa38eeaa
identifier: oo:GB-COH-00192707
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# NAPP LABORATORIES LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-00192707`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/0f811bf9-0b65-5d10-a9ae-0bc5fa38eeaa  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0f811bf9-0b65-5d10-a9ae-0bc5fa38eeaa  

## Ownership & control

### Owners / controllers

- **NAPP PHARMACEUTICAL HOLDINGS LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/658de06a-9248-5a00-8c1b-ba23cd78b41f
- **NAPP PHARMACEUTICAL HOLDINGS LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/658de06a-9248-5a00-8c1b-ba23cd78b41f

### UBO chain (walk to the ultimate owner)

A **21-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `00192707`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 1923-09-26
- **Registered office:** Unit 191 Cambridge Science Park, Milton Road, Cambridge, CB4 0GW, England
- **SIC:** 46460

### Officers

- JAMIESON, Stephen Johan — director · British · appointed 2019-02-22
- LEA, Bryan George — director · British · appointed 1999-01-29
- CORNHILL SERVICES LIMITED — corporate secretary · appointed 2008-03-25 · resigned 2009-02-26
- [TIERCEL SERVICES LIMITED](https://whiteintel.dev/entity/d2348a9e-fd33-5fbe-8b01-e46f5761851c) — corporate secretary · appointed 2009-02-26 · resigned 2018-06-11
- TIERCEL SERVICES LIMITED — corporate secretary · resigned 2008-03-25
- BAKER, Stuart David — director · American · appointed 2017-08-08 · resigned 2019-12-31
- BASHFORTH, Simon John — director · British · appointed 1994-01-24 · resigned 2012-04-06
- BROGDEN, John Robert — director · British · resigned 2005-03-30
- CHAPLIN, John Richard — director · British · resigned 1999-09-09
- HEALEY, Michael John — director · Swedish · appointed 1995-05-04 · resigned 2005-03-30
- LESLIE, Stewart T — director · British · resigned 1997-12-31
- LYNCH, Michael Howard — director · British · appointed 1999-01-29 · resigned 2012-12-31
- MANNERS, Paul — director · British · resigned 2001-12-31
- MATTESSICH, Antony Charles — director · Us · appointed 2005-04-01 · resigned 2017-07-31
- MILLER, Allan John — director · British · resigned 2003-05-29
- MITCHELL, Christopher Benbow — director · British · resigned 2018-04-12
- WIKSTROM, Ake Gunnar — director · Swedish · appointed 2018-04-12 · resigned 2019-02-22
- WIKSTROM, Ake Gunnar — director · Swedish · appointed 2001-09-05 · resigned 2011-05-19
- WILLIAMSON, Kenneth Lawrie, Dr — director · British · appointed 2002-06-28 · resigned 2009-03-31

### Beneficial owners (Persons with Significant Control)

- [Napp Pharmaceutical Group Limited](https://whiteintel.dev/entity/658de06a-9248-5a00-8c1b-ba23cd78b41f) — 75–100% shares · corporate PSC · England — since 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/00192707
- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/00192707

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **NAPP LABORATORIES LIMITED**. Human view: https://whiteintel.dev/entity/0f811bf9-0b65-5d10-a9ae-0bc5fa38eeaa · Structured JSON: https://whiteintel.dev/api/public/dossier/0f811bf9-0b65-5d10-a9ae-0bc5fa38eeaa._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._